Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
New CentoXome

Turning Years Into Days

It takes approx. 7 years to diagnose a patient with a rare disease. With NEW CentoXome®, you can turn those years into days.

Read More

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 11. Juni 2021

  • Das Planen einer Reise, egal ob privater oder beruflicher Natur, ist im Zuge der...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 9, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

New leadership team to present vision, strategy, and execution roadmap

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 7, 2020 (GLOBE NEWSWIRE) -...

Read more

Observational Study to Advance Genetic Understanding of FTD Being Conducted With Support From Alector

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 1, 2020 (GLOBE NEWSWIRE)

  • World leader and trusted partner in rare diseases releases enhanced Whole...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 27. Mai 2021

  • Von Anfang März bis zu den Pfingsttagen hat CENTOGENE allen Schülern und Schülerinnen,...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 27. Mai 2021

  • CENTOGENE, ein etablierter Experte für SARS-CoV-2-Tests mit Testzentren in Berlin,...
Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 26, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 20. Mai 2021

  • CENTOGENEs neuer 1-Stunden-Test „Premium-1“ bietet Goldstandard PCR-Analyse auch in einem...
Read more